
Glimter MF 1mg/500mg Tablet SR
Marketer
Bluewaterresearch
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glimter MF 1mg/500mg Tablet SR
Diabex Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as premature discontinuation, without medical consultation, risks elevated glucose levels and potential complications including kidney impairment, vision loss, neuropathy, and limb amputation. This medication forms part of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headaches, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic risk. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended by your doctor.
Primary Ingredients of Glimter MF 1mg/500mg Tablet SR
No text provided to rephrase.
Uses of Glimter MF 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimter MF 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimter MF 1mg/500mg Tablet SR whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Glimter MF 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimter MF 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimter MF 1mg/500mg Tablet SR whole; do not crush, chew, or fracture it. Administer this extended-release tablet with a meal.
How Glimter MF 1mg/500mg Tablet SR works:
Glimter MF SR tablets (1mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimter MF 1mg/500mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Prolonged-release Glimter MF 1mg/500mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is recommended.
Breast feedingUNSAFE
Sustained-release Glimter MF tablets (1mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Glimter MF 1mg/500mg SR tablets; dosage modification may be necessary. Physician consultation is recommended. Glimter MF 1mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Close monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glimter MF 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A low starting dose is typically recommended for those with mild to moderate liver disease; the medication is contraindicated in cases of severe liver dysfunction.
What if you forget to take Glimter MF 1mg/500mg Tablet SR :
Should you forget to take a Glimter MF 1mg/500mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimter MF 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Addictive | None. |
| Type of Medication | Medication for diabetes |
